Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.71 |
| ▸ | LMNA | P02545 | 2/20 | 0.65 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.65 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | PDE4A | P27815 | 1/20 | 0.44 |
| ▸ | MGAM | O43451 | 5/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TOP1 | P11387 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30006581 | 1.00 | TDP1 (0.71) | TDP1LMNAL3MBTL1USP2SLCO1B1 | |
| SCHEMBL1686154 | 1.00 | TDP1 (0.71) | TDP1LMNAL3MBTL1USP2SLCO1B1 | |
| SCHEMBL11197203 | 1.00 | TDP1 (0.71) | TDP1LMNAL3MBTL1USP2SLCO1B1 | |
| SCHEMBL31629817 | 1.00 | TDP1 (0.71) | TDP1LMNAL3MBTL1USP2SLCO1B1 | |
| SCHEMBL14735789 | 1.00 | TDP1 (0.71) | TDP1LMNAL3MBTL1USP2SLCO1B1 | |
| SCHEMBL1686159 | 1.00 | TDP1 (0.71) | TDP1LMNAL3MBTL1USP2SLCO1B1 | |
| SCHEMBL7989065 | 1.00 | TDP1 (0.71) | TDP1LMNAL3MBTL1USP2SLCO1B1 | |
| SCHEMBL19889196 | 0.97 | LMNA (0.69) | TDP1LMNAL3MBTL1USP2SLCO1B1 | |
| SCHEMBL20946304 | 0.97 | LMNA (0.69) | TDP1LMNAL3MBTL1USP2SLCO1B1 | |
| SCHEMBL19889263 | 0.97 | LMNA (0.69) | TDP1LMNAL3MBTL1USP2SLCO1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12187817-B2 | Preparation of ceramide conjugates and derivatives of sphingolipid analogues | KODE BIOTECH LIMITED (NZ) | 2025-01-07 | — | — | US | disclosed |
| US-20240050582-A1 | CONJUGATES INCLUDING MULTIPLE SACCHARIDIC CHAINS ON A LINEAR PROTEIN AND USES IN MAMMALS FEED | UNIVERSITEIT GENT (BE) | 2024-02-15 | — | — | US | disclosed |
| EP-4304656-A1 | CONJUGATES INCLUDING MULTIPLE SACCHARIDIC CHAINS ON A LINEAR PROTEIN AND USES IN MAMMALS FEED | Universiteit Gent (BE) | 2024-01-17 | — | — | EP | disclosed |
| US-20230374076-A1 | THE PREPARATION OF CERAMIDE CONJUGATES AND DERIVATIVES OF SPHINGOLIPID ANALOGUES | KODE BIOTECH LIMITED (NZ) | 2023-11-23 | — | — | US | disclosed |
| US-11760779-B2 | Preparation of ceramide conjugates and derivatives of sphingolipid analogues | KODE BIOTECH LIMITED (NZ) | 2023-09-19 | — | — | US | disclosed |
| WO-2022189361-A1 | CONJUGATES INCLUDING MULTIPLE SACCHARIDIC CHAINS ON A LINEAR PROTEIN AND USES IN MAMMALS FEED | UNIVERSITEIT GENT (BE) | 2022-09-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230374076-A1 | THE PREPARATION OF CERAMIDE CONJUGATES AND DERIVATIVES OF SPHINGOLIPID ANALOGUES | SGMS1, SGMS2, CERT1 | TDP1 2954/4885LMNA 76/4885L3MBTL1 1439/4885 |
| US-11760779-B2 | Preparation of ceramide conjugates and derivatives of sphingolipid analogues | SGMS1, SGMS2, CERT1 | TDP1 2787/4885LMNA 107/4885L3MBTL1 1635/4885 |
| US-12187817-B2 | Preparation of ceramide conjugates and derivatives of sphingolipid analogues | SGMS1, SGMS2, CERT1 | TDP1 2766/4885LMNA 113/4885L3MBTL1 1662/4885 |
| US-20240050582-A1 | CONJUGATES INCLUDING MULTIPLE SACCHARIDIC CHAINS ON A LINEAR PROTEIN AND USES IN MAMMALS FEED | PIGS, B3GAT3, GALNT3 | TDP1 4612/4885LMNA 2908/4885L3MBTL1 697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.